阿司匹林联合拉贝洛尔对妊娠期高血压患者血压、炎症因子、沉默信息调节因子的影响OA
Effects of Aspirin Combined with Labetalol on Blood Pressure,Inflammatory Factors and Silent Information Regulators in Patients with Hypertension in Pregnancy
目的:探讨75mg/d剂量阿司匹林联合拉贝洛尔对妊娠期高血压患者血压、炎症因子、沉默信息调节因子(SIRTs)的影响.方法:选取2022年3月～2023年3月期间于某院治疗的92例妊娠期高血压患者作为研究对象,采用随机数字表法分为对照组和观察组,每组46例.两组患者均给予镇静、扩容及限制盐摄入等常规治疗,对照组患者在常规治疗基础上加用盐酸拉贝洛尔片,观察组患者在对照组治疗基础上加用阿司匹林肠溶片.比较两组患者血压(收缩压、舒张压)、炎症因子[白介…查看全部>>
Objective:To investigate the effects of 75mg/d aspirin combined with labetalol on blood pressure,inflammatory factors and silent information regulators(SIRTs)in patients with hypertension in pregnancy.Methods:A total of 92 hypertension in pregnancy patients treated in a hospital from March 2022 to March 2023 were selected and divided into the control group and observation group by random number table method,with 46 patients in each group.Both groups were giv…查看全部>>
李梦竹;李瓅;周亚丹
郑州市中心医院产科,郑州 450000郑州市中心医院产科,郑州 450000郑州市中心医院产科,郑州 450000
临床医学
阿司匹林拉贝洛尔妊娠期高血压炎症因子沉默信息调节因子
aspirinlabetalolhypertension in pregnancyinflammatory factorssilent information regulators
《中国合理用药探索》 2024 (6)
76-81,6
河南省医学科技攻关计划项目(LHGJ20210239)
评论